{"id":25171,"date":"2025-06-05T09:16:38","date_gmt":"2025-06-05T09:16:38","guid":{"rendered":"https:\/\/www.euforea.org\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/"},"modified":"2026-08-20T07:56:57","modified_gmt":"2026-08-20T07:56:57","slug":"astma-en-crswnp-de-lat-hoger-leggen-met-remissie","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/","title":{"rendered":"Astma en CRSwNP: de lat hoger leggen met remissie"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"25171\" class=\"elementor elementor-25171 elementor-14672\" data-elementor-post-type=\"news\">\n\t\t\t\t<div class=\"elementor-element elementor-element-48a9837 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"48a9837\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-516a6b9 elementor-widget elementor-widget-euforea_general_content\" data-id=\"516a6b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_content.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n    <div data-quickedit-entity-id=\"paragraph\/842\" class=\"paragraph paragraph--text-columns paragraph-id--842 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n      <div class=\"inner--wide\">\n        <div class=\"text__text text text--paragraph\">\n        \t          <p>Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP). Dit vertegenwoordigt een verschuiving van het traditionele doel van symptoombeheersing naar een ambitieuzere en uitgebreidere zorgstandaard. Jarenlang werd het concept van remissie bij deze aandoeningen over het hoofd gezien, in tegenstelling tot bij veel andere chronische ziekten. Dat paradigma is nu aan het veranderen. Vooruitgang in de behandeling \u2014 waaronder gerichte therapie\u00ebn, gepersonaliseerde benaderingen, preventieve strategie\u00ebn en multidisciplinaire zorg \u2014 stelt clinici in staat om remissie na te streven als een realistisch doel voor pati\u00ebnten met ernstige astma en CRSwNP.   <\/p>\n<p>Om deze evolutie te ondersteunen, heeft EUFOREA een consensusverklaring uitgebracht waarin remissie bij zowel astma als CRSwNP wordt gedefinieerd. Dit initiatief is bedoeld om de taal die door zorgverleners wordt gebruikt op \u00e9\u00e9n lijn te brengen en tegelijkertijd pati\u00ebnten te helpen de doelstellingen van hun behandeling beter te begrijpen. Remissie is niet langer slechts een ambitieus doel \u2014 het is hard op weg de \u201cheilige graal\u201d van de moderne respiratoire zorg te worden.  <\/p>\n<p>In deze aflevering nodigt EUFOREA <strong>Professor Yvonne Chan<\/strong> uit, Otolaryngologist-in-Chief in het St. Michael's Hospital in Toronto en Associate Professor aan de afdeling Otolaryngology - Head & Neck Surgery aan de Universiteit van Toronto, evenals <strong>Professor Michael Wechsler<\/strong>, hoogleraar Geneeskunde aan het National Jewish Health ziekenhuis in Denver, Colorado in de Verenigde Staten, en directeur van het NJH Cohen Family Asthma Institute binnen de divisie Pulmonary, Critical Care and Sleep Medicine.<\/p>\n        <\/div>\n      <\/div>\n    <\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-15ce672 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"15ce672\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ede88f3 elementor-widget elementor-widget-video\" data-id=\"ede88f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/lg-yxTr36rg&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP). Dit vertegenwoordigt een verschuiving van het traditionele doel van symptoombeheersing naar een ambitieuzere en uitgebreidere zorgstandaard. Jarenlang werd het concept van remissie bij deze aandoeningen over het hoofd gezien, in tegenstelling tot bij veel andere chronische ziekten. Dat paradigma is nu aan het veranderen. Vooruitgang in de behandeling \u2014 waaronder gerichte therapie\u00ebn, gepersonaliseerde benaderingen, preventieve strategie\u00ebn en multidisciplinaire zorg \u2014 stelt clinici in staat om remissie na te streven als een realistisch doel voor pati\u00ebnten met ernstige astma en CRSwNP. Om deze evolutie te ondersteunen, heeft EUFOREA een consensusverklaring uitgebracht waarin remissie bij zowel astma als CRSwNP wordt gedefinieerd. Dit initiatief is bedoeld om de taal die door zorgverleners wordt gebruikt op \u00e9\u00e9n lijn te brengen en tegelijkertijd pati\u00ebnten te helpen de doelstellingen van hun behandeling beter te begrijpen. Remissie is niet langer slechts een ambitieus doel \u2014 het is hard op weg de \u201cheilige graal\u201d van de moderne respiratoire zorg te worden. In deze aflevering nodigt EUFOREA Professor Yvonne Chan uit, Otolaryngologist-in-Chief in het St. Michael&#8217;s Hospital in Toronto en Associate Professor aan de afdeling Otolaryngology &#8211; Head &#038; Neck Surgery aan de Universiteit van Toronto, evenals Professor Michael Wechsler, hoogleraar Geneeskunde aan het National Jewish Health ziekenhuis in Denver, Colorado in de Verenigde Staten, en directeur van het NJH Cohen Family Asthma Institute binnen de divisie Pulmonary, Critical Care and Sleep Medicine.<\/p>\n","protected":false},"author":9,"featured_media":25173,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[149],"tags":[],"class_list":["post-25171","news","type-news","status-publish","has-post-thumbnail","hentry","category-euforea-news-shows"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Astma en CRSwNP: de lat hoger leggen met remissie - EUFOREA<\/title>\n<meta name=\"description\" content=\"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Astma en CRSwNP: de lat hoger leggen met remissie\" \/>\n<meta property=\"og:description\" content=\"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T07:56:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1748\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/\",\"name\":\"Astma en CRSwNP: de lat hoger leggen met remissie - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"datePublished\":\"2025-06-05T09:16:38+00:00\",\"dateModified\":\"2026-08-20T07:56:57+00:00\",\"description\":\"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Astma en CRSwNP: de lat hoger leggen met remissie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Astma en CRSwNP: de lat hoger leggen met remissie - EUFOREA","description":"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/","og_locale":"nl_NL","og_type":"article","og_title":"Astma en CRSwNP: de lat hoger leggen met remissie","og_description":"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).","og_url":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-20T07:56:57+00:00","og_image":[{"width":1748,"height":1015,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/","url":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/","name":"Astma en CRSwNP: de lat hoger leggen met remissie - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","datePublished":"2025-06-05T09:16:38+00:00","dateModified":"2026-08-20T07:56:57+00:00","description":"Remissie is naar voren gekomen als de nieuwe maatstaf bij de behandeling van zowel astma als chronische rhinosinusitis met neuspoliepen (CRSwNP).","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/astma-en-crswnp-de-lat-hoger-leggen-met-remissie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Astma en CRSwNP: de lat hoger leggen met remissie"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=25171"}],"version-history":[{"count":1,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25171\/revisions"}],"predecessor-version":[{"id":25175,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25171\/revisions\/25175"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/25173"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=25171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=25171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=25171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}